Soleno Therapeutics (SLNO) Shareholder's Equity (2013 - 2026)

Soleno Therapeutics (SLNO) Shareholder's Equity (2013 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shareholder's Equity (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 7.14 Bn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 795.79 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 595,226.00
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 1.00 Bn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 14.38 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 19.36 Bn
9 Abivax 91.96 Bn 91.96 Bn - 502.95 Mn
10 Soleno Therapeutics 2.76 Bn 2.51 Bn 93.41 Mn 495.80 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 495.80 Mn
Dec 31, 2025 450.12 Mn
Sep 30, 2025 494.81 Mn
Jun 30, 2025 240.14 Mn
Mar 31, 2025 232.26 Mn
Dec 31, 2024 245.11 Mn
Sep 30, 2024 264.70 Mn
Jun 30, 2024 280.76 Mn
Mar 31, 2024 143.39 Mn
Dec 31, 2023 157.51 Mn
Sep 30, 2023 23.22 Mn
Jun 30, 2023 12.43 Mn
Mar 31, 2023 2.64 Mn
Dec 31, 2022 10.35 Mn
Sep 30, 2022 15.20 Mn
Jun 30, 2022 20.31 Mn
Mar 31, 2022 26.46 Mn
Dec 31, 2021 17.79 Mn
Sep 30, 2021 20.20 Mn
Jun 30, 2021 27.44 Mn